Catheter Precision announced its audit opinion raised concerns about ongoing financial stability, as detailed in its recent 10-K report.
Quiver AI Summary
Catheter Precision, Inc. has announced that its 2024 annual financial report includes an audit opinion indicating substantial doubt about its ability to continue as a going concern. This was disclosed in compliance with NYSE American guidelines and follows the filing of its Form 10-K on March 31, 2025. The company emphasized that this announcement does not change or amend its previously filed consolidated financial statements or annual report.
Potential Positives
- Compliance with NYSE American Company Guide Section 610(b) demonstrates the company's adherence to regulatory requirements.
- The press release provides transparency regarding the audit opinion, which is important for maintaining investor trust.
- Having already communicated the going concern issue in the Annual Report suggests the company is proactively managing investor expectations.
Potential Negatives
- The company received an audit opinion containing a Substantial Doubt Regarding Going Concern, indicating potential financial instability.
- This announcement shows that the company is in a position where its ability to continue operations might be questioned by investors and stakeholders.
FAQ
What is the recent announcement from Catheter Precision, Inc.?
Catheter Precision, Inc. announced a substantial doubt regarding its going concern as per its recent audited financial statements.
Why was there a doubt about going concern for Catheter Precision?
The doubt arises from an audit opinion included in the company's Annual Report on Form 10-K for the year ended December 31, 2024.
What does the term 'going concern' mean?
'Going concern' refers to a company's ability to continue its operations for the foreseeable future without significant financial distress.
What is required by NYSE American Company Guide Section 610(b)?
This section mandates a public announcement when a company receives an audit opinion that includes a going concern paragraph.
How can I contact Catheter Precision for more information?
You can contact David Jenkins at 973-691-2000 or email [email protected] for further inquiries.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
Full Release
Fort Mill, S.C., April 17, 2025 (GLOBE NEWSWIRE) -- -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2024, filed March 31, 2025, with the Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included a Substantial Doubt Regarding Going Concern paragraph. See further discussion in footnote 1 to the Company's consolidated financial statements included in the Company's Annual Report on Form 10-K.
This announcement is made pursuant to NYSE American Company Guide Section 610(b), which requires separate public announcement of the receipt of an audit opinion containing a going concern paragraph. This announcement does not represent any change or amendment to the Company's consolidated financial statements or to its Annual Report on Form 10-K for the year ended December 31, 2024.
CONTACTS:
At the Company
David Jenkins
973-691-2000
[email protected]
